Kinnate Biopharma Inc.

• SAN DIEGO, CA

How do I update this listing?

Create Email Alert

Kinnate Biopharma is based out of San Diego. Kinnate Biopharma Inc. is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Kinnate��s mission is to expand the reach of targeted therapeutics by developing products for underserved populations. The firm last filed a Form D notice of exempt offering of securities on 2020-08-31. The notice included securities offered of Equity

Contact Info

kinnate biopharma inc.
11975 EL CAMINO REAL, STE 101
SAN DIEGO CA 92130
Business Phone: 8582994699

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold
2020-08-31	D/A	BIOTECHNOLOGY	Equity	97,999,937	97,999,937
2020-08-04	D	BIOTECHNOLOGY	Equity	87,999,943	87,999,943
2019-12-23	D	PHARMACEUTICALS	Equity	74,499,991	74,499,991

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
STEPHEN W. KALDOR	subscription required	EXECUTIVE OFFICER DIRECTOR PROMOTER
ERIC W. MURPHY	subscription required	EXECUTIVE OFFICER DIRECTOR
BRET W. ZBAR	subscription required	DIRECTOR
CARL W. GORDON	subscription required	DIRECTOR
MICHAEL W. ROME	subscription required	DIRECTOR
NIMA W. FARZAN	subscription required	EXECUTIVE OFFICER DIRECTOR
JIM TANANBAUM	subscription required	DIRECTOR
MARK MELTZ	subscription required	EXECUTIVE OFFICER
KEITH FLAHERTY	subscription required	DIRECTOR
DEAN MITCHELL	subscription required	DIRECTOR
LAURIE SMALDONE ALSUP	subscription required	DIRECTOR